Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.44 +0.01 (+3.00%)
As of: Oct 21, 2026 · 11:40 AM EDT

Reviva Pharmaceuticals Holdings (RVPH) Revenue (2019 - 2020)

Updated

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Revenue (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 16.99 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn 15.03 Bn
10 Reviva Pharmaceuticals Holdings 5.68 Mn -64.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 3,800.00
Aug 31, 2020 9,892.00
May 31, 2020 109,175.00
Feb 29, 2020 1.20 Mn
Nov 30, 2019 323,704.00
Aug 31, 2019 351,738.00
May 31, 2019 398,746.00
Feb 28, 2019 -344,689.00
API Access

Reviva Pharmaceuticals Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RVPH&period=max&api_key=YOUR_API_KEY